You are here

Home

Clinical Trials: Heart Attack

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 25, 2016 - 12:00
EXpanded CELL ENdocardiac Transplantation (EXCELLENT)
Condition:   Acute Myocardial Infarction
Interventions:   Drug: PROTHERACYTES;   Device: Standard of Care (Percutaneous Transluminal Coronary Angioplasty and stent(s) implantation)
Sponsor:   CellProthera
Recruiting - verified February 2016
Posted: Thursday, January 21, 2016 - 12:00
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)
Conditions:   Acute Myocardial Infarction;   Myocardial Infarction;   Ischemic Cardiomyopathy
Intervention:   Biological: umbilical cord mesenchymal stem cells
Sponsors:   South China Research Center for Stem Cell and Regenerative Medicine;   Sun Yat-sen University
Not yet recruiting - verified January 2016
Posted: Wednesday, January 6, 2016 - 12:00
Mobilization of Endothelial Progenitor Cells and Aspirin
Condition:   Hypertrophic Obstructive Cardiomyopathy
Intervention:   Drug: Aspirin
Sponsor:   Ottawa Heart Institute Research Corporation
Recruiting - verified May 2016
Posted: Tuesday, July 14, 2015 - 12:00
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
Conditions:   Myocardial Infarction;   Acute Myocardial Infarction;   Ischemic Cardiomyopathy
Intervention:   Biological: BMMSCs
Sponsors:   Academy Military Medical Science, China;   Sun Yat-sen University
Not yet recruiting - verified July 2015
Posted: Tuesday, May 5, 2015 - 12:00
CardiAMP™ Heart Failure Trial
Condition:   Heart Failure
Interventions:   Biological: Autologous cell therapy;   Device: CardiAMP cell therapy;   Other: Sham
Sponsor:   BioCardia, Inc.
Not yet recruiting - verified October 2015
Posted: Monday, May 4, 2015 - 12:00
The Transendocardial Autologous Cells (hMSC or hMSC and hCSC) in Ischemic Heart Failure Trial (TAC-HFT II)
Conditions:   Chronic Ischemic Left Ventricular Dysfunction;   Myocardial Infarction
Interventions:   Drug: Autologous hMSCs;   Drug: Autologous Human C-Kit CSCs II;   Drug: Placebo
Sponsor:   Joshua M Hare
Not yet recruiting - verified April 2016
Posted: Wednesday, March 25, 2015 - 12:00
Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome
Condition:   Hypoplastic Left Heart Syndrome
Interventions:   Drug: Allo-hMSCs;   Drug: Placebo
Sponsors:   Joshua M Hare;   University of Maryland
Recruiting
Posted: Tuesday, March 10, 2015 - 12:00
Role of Immune Responses After Acute Myocardial Infarction
Condition:   Myocardial Fibrosis
Interventions:   Drug: Rosuvastatin plus clopidogrel;   Drug: Rosuvastatin plus ticagrelor;   Drug: Simvastatin plus clopidogrel;   Drug: Simvastatin plus ticagrelor
Sponsors:   Federal University of São Paulo;   FAPESP - Fundação de Apoio à Pesquisa do Estado de São Paulo
Recruiting - verified June 2015
Posted: Tuesday, February 3, 2015 - 12:00
Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy
Condition:   Ischemic Cardiomyopathy
Interventions:   Biological: WJMSCs Vs. placebo;   Biological: Placebo
Sponsors:   Navy General Hospital, Beijing;   First People's Hospital of Foshan;   General Hospital of Armed Police, Beijing;   PLA General Hospital, Beijing
Not yet recruiting - verified January 2015
Posted: Thursday, December 18, 2014 - 12:00
Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI
Conditions:   Heart Failure;   Myocardial Infarction
Intervention:   Procedure: Intracoronary infusion of BM-MC
Sponsor:   American Heart of Poland
Not yet recruiting - verified December 2014

Pages